Nordea Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Nordea Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$940K	Buy	+54,227	New	+$743K	﹤0.01%	852

Other funds holding AMRX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management's AMRX Position: Q2 2026 in Review

Nordea Investment Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 54,227 shares worth $940K. The stake represents ﹤0.01% of the portfolio and ranks #852 among its holdings.

107 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Nordea Investment Management held 54,227 shares of Amneal Pharmaceuticals worth $940K as of Q2 2026.
Amneal Pharmaceuticals was a new Nordea Investment Management position in Q2 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Nordea Investment Management's portfolio in Q2 2026, its #852 holding.
107 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.